AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05789706 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dayamed Arthur a novel intelligent medication adherence platform
Description: Novel smart phone adherence application configured with subject pharmacy data providing accurate reminders of when to take medications and providing auditable user feed back to clinical care teams for patient response directed provider intervention.
Study NCT05536557 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bilateral External Oblique İntercostal (EOI) Plane Block
Description: External Oblique İntercostal (EOI) Plane Block will be provided for postoperative pain for Laparoscopic Cholecystectomy with Bupivacaine. And patients will receive standard multimodal analgesia comprising paracetamol, deksketoprofen, and tramadol.
Study NCT05536557 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Standard perioperative and postoperative multimodal analgesia
Description: Patients will receive standard multimodal analgesia comprising paracetamol, deksketoprofen, and tramadol for Laparoscopic Cholecystectomy.
Study NCT05524857 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fedratinib Oral Capsule 300 mg
Description: 300 mg by mouth, once daily
Study NCT05524857 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine 20 mg/m2
Description: 20 mg/m2 for injection, for intravenous use
Study NCT05524857 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fedratinib Oral Capsule 400 mg
Description: 400 mg by mouth, once daily
Study NCT05733234 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser ,Fotona, Light Walker AT, Ljubljana, Slovenia
Description: Laser is used adjunctively in the surgical treatment of peri-implantitis for decontamination of the implant surface
Study NCT05733234 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mechanical Treatment
Description: Dental instrument is used in combination with Chlorhexidine to decontaminate the implant surface
Study NCT05577000 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Manufactured Anti-BCMA CAR-T cells
Description: Given IV
Study NCT05194137 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: a proprioception protocol associated with vaginal palpation and feedback
Description: A total of 13 previously established examples of voice commands can be used by the physiotherapists to help women understand how to perform a PFM contraction.
Study NCT05194137 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: a proprioception protocol associated with biofeedback
Description: The software has five different interfaces for visualize PFM contraction: sign itself and signal transformed into the movement of a balloon; an airplane; a fairy; or a bird. Positive reinforcements will be verbalized after each PFM contraction using one of 4 previously established examples of voice commands.
Study NCT06328062 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirogabalin
Description: Participants will receive 5 mg of mirogabalin, taken as half a tablet, every day twice a day, after breakfast and dinner, for 6 weeks.
Study NCT06328062 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pregabalin
Description: Participants will receive 50 mg of pregabalin, taken as a tablet, every day twice a day, after breakfast and dinner, for 6 weeks.
Study NCT05524155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HAIC
Description: hepatic arterial infusion (HAI) of oxaliplatin, fluorouracil/leucovorin (FOLFOX) treatment
Study NCT05524155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: 200mg IV d1,Q3W
Study NCT05524155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regorafenib
Description: 80mg/day,PO,QD,d1～21,Q4W
Study NCT06254404 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Low dose protamine
Description: Administration of 70% of the normal dose of protamine
Study NCT06254404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low dose protamine
Description: Administration of 70% of the normal dose of protamine
Study NCT06180070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nuromol® tablets
Description: 1 tablet of 200mg Ibuprofen/ 500mg Paracetamol
Study NCT06180070 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nuromol® tablets
Description: 1 tablet of 200mg Ibuprofen/ 500mg Paracetamol
Study NCT05577000 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV
Study NCT04562727 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy
Description: perioperative chemotherapy or postoperative chemotherapy
Study NCT04562727 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: perioperative chemotherapy or postoperative chemotherapy
Study NCT06511284 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High protein dose
Description: High dose of protein (2.0 g/kg) will prescribed for home enteral nutrition
Study NCT06511284 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual protein dose
Description: Usual dose of protein (1.5 g/kg) will prescribed for home enteral nutrition
Study NCT04643574 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NeoTIL
Description: Adoptive transfer of ex vivo expanded Autologous Tumor-Infiltrating Lymphocytes enriched for tumor antigen specificity (NeoTIL)
Study NCT05102812 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breakfast Group Intervention
Description: An actionable toolkit encompassing an assessment, a personalised care plan and a range of outcome measures.
Study NCT05577000 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV
Study NCT04643574 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Cyclophosphamide will be administered as an intravenous (IV) infusion for two days.
Study NCT04643574 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Fludarabine will be administered as an intravenous (IV) infusion for five days.
Study NCT05337735 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XmAb20717
Description: Given by vein (IV)
Study NCT04995731 — intervention group
Intervention type: BEHAVIORAL
Intervention: Information about clinical risk factors for endometrial cancer and endometrial hyperplasia (EH)
Description: Bleeding type, age, race, parity, early menarche or late menopause, body mass index, body composition, hypertension, type II diabetes, anovulation, polycystic ovary syndrome and smoking history. Other epidemiologic risk factors including tamoxifen exposure, history of breast cancer, current hormone therapy use, anticoagulant use, oral contraception use, family history of endometrial, breast or colon cancer.
Study NCT04995731 — intervention group
Intervention type: PROCEDURE
Intervention: transvaginal ultrasound examination
Description: All patients will undergo a standard transvaginal ultrasound examination followed by power Doppler endometrial vascularity assessment. After ultrasound examination, all patients will undergo endometrial sampling either through hysteroscopy or dilatation and curettage operation (D, C) or will have histopathological evaluation of biopsy specimens obtained by hysterectomy. Histopathological evaluation will serve as a gold standard for the ﬁnal diagnosis.
Study NCT04985201 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Irinotecan
Description: Irinotecan intravenous infusion was administered at a dose of 60 mg/m\^2 on Day 1,8 of each 21-day cycle.
Study NCT04985201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: Irinotecan intravenous infusion was administered at a dose of 60 mg/m\^2 on Day 1,8 of each 21-day cycle.
Study NCT04985201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simvastatin
Description: Simvastatin 40 mg daily oral tablet taken.
Study NCT05421624 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Digital music therapeutic
Description: The digital music therapeutic is comprised of foot sensors, a smart phone with pre-installed proprietary software application, and headphones. The device obtains real-time walking data through movement sensors that communicate wirelessly with the smartphone application software. Music cues are tailored to the person's walking pattern, and are transmitted wirelessly to the headphones. Music cues are time-shifted to the user's baseline cadence and adjusted in real-time based on the user's walking performance metrics.
Study NCT05421624 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active-Control
Description: The Active-Control intervention will implement a similarly structured community-based walking program as Amped-PD, with the only exception the digital music therapeutic.
Study NCT04643574 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Interleukin-2
Description: After TIL infusion, IL-2 (optional) will be started as a bolus administration every eight hours, for a maximum of fourteen doses.
Study NCT04643574 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Low-dose irradiation (1Gy) will be administered using tomotherapy to tumor lesions once before NeoTIL infusion.
Study NCT05136209 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PCCC procedure without A-vit
Description: In this randomized clinical trial, patients receive cataract surgery on both eyes on the same day. For each patient, one eye is randomly assigned to undergo PCCC+A-Vit procedure, while the fellow eye is undergoing PCCC procedure without A-Vit.
Study NCT05136209 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PCCC+A-Vit procedure
Description: PCCC+A-Vit procedure
Study NCT06039904 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Natural rubber knee support
Description: The knee support comprised two parts, the support body and the protective cushion. Which were categorized into four sizes, S, M, L and XL according to widths and lengths, as follows: size S, 8x17 cm; size M, 10x19 cm; size L, 12x24 cm; and size XL, 14x28 cm. The support body was made of stretchable natural cotton fabrics, which were comfortable, breathable, washable, less irritant and flexible. Similarly, the protective cushion was classified into four sizes: S, M, L and XL with diameters (based on the patellar diameters) of 5, 6, 7 and 8 cm, respectively. Cushions were made from either natural rubber and inserted at the front of the support body (to cover the patellar).
Study NCT06039904 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sponge knee support
Description: The knee support comprised two parts, the support body and the protective cushion. Which were categorized into four sizes, S, M, L and XL according to widths and lengths, as follows: size S, 8x17 cm; size M, 10x19 cm; size L, 12x24 cm; and size XL, 14x28 cm. The support body was made of stretchable natural cotton fabrics, which were comfortable, breathable, washable, less irritant and flexible. Similarly, the protective cushion was classified into four sizes: S, M, L and XL with diameters (based on the patellar diameters) of 5, 6, 7 and 8 cm, respectively. Cushions were made from either sponge and inserted at the front of the support body (to cover the patellar).
Study NCT05230264 — intervention group
Intervention type: OTHER
Intervention: Elective AAA Repair
Description: Elective AAA Repair - Observation of Stress Response
Study NCT05335044 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-331
Description: QD, PO
Study NCT05335044 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EX5619
Description: QD, PO
Study NCT06174948 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CUE1 non-invasive device
Description: This is a 9-week feasibility study which will involve wearing the CUE1 device on a daily basis at participants' homes while they continue their usual activities of daily living (ADL). The CUE1 is a non-invasive medical device which delivers low frequency metronomes like tactile cueing and high frequency focused vibrotactile stimulation. All participants will be using the same pre-programmed settings for the CUE1 device which are: vibration strength delivered at 80%, pulse length 800 milliseconds (ms), and rest length 800ms as set at baseline and will not change. The CUE1 device is attached to the skin via an adhesive patch which has been dermatologically tested and approved. Participants will be provided with the adhesive patches and shown how to use them and the CUE1 device by the research team.
Study NCT06174948 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: CUE1+ device active vs sham CUE1+ device
Description: 30-40 participants with idiopathic Parkinson's disease only will be randomly allocated to one of two interventions groups: one group will use the active CUE1+ device while the other group will use the CUE1+ at silent settings (e.g., sham device). All participants will use their device in the same way which is starting the usage from the morning, within an hour once they took their medications for Parkinson's (if any) and continue using the device for 8 hours, once a day, every day for 12 weeks
Study NCT06174948 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CUE1+ device active vs sham CUE1+ device
Description: 30-40 participants with idiopathic Parkinson's disease only will be randomly allocated to one of two interventions groups: one group will use the active CUE1+ device while the other group will use the CUE1+ at silent settings (e.g., sham device). All participants will use their device in the same way which is starting the usage from the morning, within an hour once they took their medications for Parkinson's (if any) and continue using the device for 8 hours, once a day, every day for 12 weeks
Study NCT04638816 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Restylane Volyme
Description: Hyaluronic Acid: Injectable gel for contouring effect (of cheek volumization).
Study NCT04638816 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Restylane Lyft Lidocaine
Description: Hyaluronic Acid: Injectable gel for projection effect (of cheek augmentation).
Study NCT05208255 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: NEP is a multimodal exercise program including different motor coordination exercises and cognitive tasks. Exercises are progressed from simple to complex tasks. Varied equipment (such as different sized balls, rackets, tulles, exercises balls, eye bands, ropes etc.) is used during different exercises containing cross-limb movements, throwing, jumping, walking, and cognitive tasks. Although the stages of the NEP and exercise selection are the same for each participant, the use of materials or cognitive tasks selection may differ according to the age and skill of the participant. The cognitive tasks were performed by using different visual (colored cards, numbered cards etc.) or auditory cues.~Motor Imagery Program: Motor imagery (MI) is a dynamic mental state during which the representation of a given motor movement is rehearsed in working memory without overt motor output. MI training will be performed in the form of imagined NEP exercises in the last 15 minutes of the session.
Study NCT05208255 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: NEP is a multimodal exercise program including different motor coordination exercises and cognitive tasks. Exercises are progressed from simple to complex tasks. Varied equipment (such as different sized balls, rackets, tulles, exercises balls, eye bands, ropes etc.) is used during different exercises containing cross-limb movements, throwing, jumping, walking, and cognitive tasks. Although the stages of the NEP and exercise selection are the same for each participant, the use of materials or cognitive tasks selection may differ according to the age and skill of the participant. The cognitive tasks were performed by using different visual (colored cards, numbered cards etc.) or auditory cues.~Motor Imagery Program: Motor imagery (MI) is a dynamic mental state during which the representation of a given motor movement is rehearsed in working memory without overt motor output. MI training will be performed in the form of imagined NEP exercises in the last 15 minutes of the session.
Study NCT06315985 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental group: Listenning to the Turkish Classical Music to pregnant women diagnosed with preeclampsia
Description: The music to be used in the research will be applied together with midwifery practices and is not a treatment option, tool or treatment option for any disease. Although listening to Classical Turkish music has no effect on treatment and care, it does not have a harmful effect on pregnant women. The participant can withdraw from the study at any time without giving any reason. The Personal Information Form, Perceived Stress Scale, and Pittsburgh Sleep Quality Index (PSQI) will be administered to the pregnant women in both groups participating in the study by face-to-face interviews with the individuals on the first day of their admission to the clinic. At the end of the third day, the Perceived Stress Scale and Pittsburgh Sleep Quality Index (PSQI) scales will be re-administered to both groups.
Study NCT04967443 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prazosin HCl 2mg
Description: Prazosin HCL 1 X 2 mg capsule.
Study NCT04967443 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prazosin HCl 2mg
Description: Prazosin HCL 1 X 2 mg capsule.
Study NCT04967443 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prazosin HCl 1 mg
Description: Prazosin HCl 2 X 1 mg capsule.
Study NCT04967443 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prazosin HCl 5 mg
Description: Prazosin HCL 1 X 5 mg capsule.
Study NCT04658953 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ultrasound guided infiltration
Description: In the patient in prone position, an infiltration guided by ultrasound will be performed in three puncture points (L3-L4, L4-L5 and L5-S1 levels unilaterally). At each level, 1mL of a mixture consisting of 3mL of Linisol 2% (60mg of lidocaine) and 1mL of Depomedrol 40mg / Lidocaine 10mg is injected.
Study NCT04658953 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fluoroscopy guided infiltration
Description: In the patient in prone position, an infiltration guided by fluoroscopy will be performed in three puncture points (L3-L4, L4-L5 and L5-S1 levels unilaterally). At each level, 1mL of a mixture consisting of 3mL of Linisol 2% (60mg of lidocaine) and 1mL of Depomedrol 40mg / Lidocaine 10mg is injected.
Study NCT06525207 — intervention group
Intervention type: DEVICE
Intervention: Impedance Planimetry, High-definition anorectal manometry and Pelvic Floor Ultrasonography
Description: Global morpho-functional assessment of the anal sphincter complex using Impedance Planimetry, High-definition anorectal manometry and Pelvic Floor Ultrasonography
Study NCT06153329 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: THDB0206 injection
Description: 0.2 U/kg, single-dose administration, subcutaneous injection 5 cm laterally from the belly button on the left or right side of the abdominal wall
Study NCT06153329 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Humalog®
Description: 0.2 U/kg, single-dose administration, subcutaneous injection 5 cm laterally from the belly button on the left or right side of the abdominal wall
Study NCT06153329 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BC222insulin lispro injection
Description: 0.2 U/kg, single-dose administration, subcutaneous injection 5 cm laterally from the belly button on the left or right side of the abdominal wall
Study NCT05071469 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Description: KT was applied.
Study NCT05071469 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan Mobilization Technique
Description: MMT was applied
Study NCT05184218 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IGM-6268
Description: Active Comparator
Study NCT05184218 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo Comparator
Study NCT04766398 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: KHK7791
Description: oral administration
Study NCT06259487 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Coordinated Vaccination
Description: Coordinated Vaccination against Respiratory Syncytial Virus (RSV) and influenza provided by the research team (i.e., during cardiology visits)
Study NCT06259487 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Following recommendations
Description: Guidance on following the standard recommendations for protective vaccinations (i.e., receiving vaccinations at vaccination points).
Study NCT06312410 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: VIA Family 2.0
Description: Multidisciplinary team based preventive intervention. For details, please see arm/group description.
Study NCT06312410 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VIA Family 2.0
Description: Multidisciplinary team based preventive intervention. For details, please see arm/group description.
Study NCT04766398 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: oral administration
Study NCT05845814 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Coformulated favezelimab/pembrolizumab
Description: Coformulated favezelimab/pembrolizumab (800 mg/200 mg) IV infusion
Study NCT05541627 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: AB-1001 Gene Therapy
Description: One-time intracerebral bilateral injections of AB-1001 (AAVrh10.CAG.hCYP46A1), an adeno-associated viral vector serotype Rh10 containing the human cholesterol 24-hydroxylase gene